Note 12 - Intangible Assets, Net (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2024

Dec. 31, 2023

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

	March 31, 2024
	(Unaudited)
	Gross amount		Accumulated amortization			Net Amount
Pharmacy records	$	8,130	$	(1,219	)	$	6,911
Trade names		4,700		(353	)		4,347
Developed technology		2,880		(432	)		2,448
Customer Contracts		250		(231	)		19
Total intangible assets	$	15,960	$	(2,235	)	$	13,725

	December 31, 2023
	(Audited)
	Gross amount		Accumulated amortization			Net Amount
Pharmacy records	$	8,130	$	(807	)	$	7,323
Trade names		4,700		(224	)		4,476
Developed technology		2,880		(281	)		2,599
Customer Contracts		250		(225	)		25
Total intangible assets	$	15,960	$	(1,537	)	$	14,423

	December 31, 2023
	Gross amount		Accumulated amortization			Net Amount
Pharmacy records	$	8,130	$	(807	)	$	7,323
Trade names		4,700		(224	)		4,476
Developed technology		2,880		(281	)		2,599
Customer Contracts		250		(225	)		25
Total intangible assets	$	15,960	$	(1,537	)	$	14,423

	December 31, 2022
	Gross amount		Accumulated amortization			Net Amount
Pharmacy records	$	—	$	—		$	—
Trade names		—		—			—
Developed technology		—		—			—
Customer Contracts		250		(200	)		50
Total intangible assets	$	250	$	(200	)	$	50

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Year		Amount
2024 (remaining nine months)	$	2,023
2025		2,672
2026		2,672
2027		2,672
2028		1,571
Thereafter		2,115
Total	$	13,725

		Amount
2024	$	2,721
2025		2,672
2026		2,672
2027		2,672
2028		1,571
Thereafter		2,115
Total	$	14,423